Search Results - "Sedukhina AS"

PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition.

Authors: Pae, Sookhee Sedukhina, Anna S. Sugiyama, Runa et al.

Source: Scientific Reports. 12/28/2024, Vol. 14 Issue 1, p1-11. 11p.

EXO1 overexpression induces homologous recombination deficiency and enhances PARP inhibitor sensitivity in ER-positive breast cancer: modulation by N4BP2L2-Mediated restoration.

Authors: Sugiyama R Sedukhina AS Sato E et al.

Source: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2025 Nov 14; Vol. 13, pp. 1695627. Date of Electronic Publication: 2025 Nov 14 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE

A new bioinformatics approach identifies overexpression of GRB2 as a poor prognostic biomarker for prostate cancer.

Authors: Iwata, Teppei Sedukhina, Anna S. Kubota, Manabu et al.

Source: Scientific Reports. 3/11/2021, Vol. 11 Issue 1, p1-8. 8p.

Author Index.

Source: FEBS Journal. Sep2014 Supplement, Vol. 281, p785-808. 24p.

Targeting the NF-κB Pathway in Cancer: Mechanisms, Resistance, and Therapeutic Potential Across Tumor Types.

Authors: Lukas, Kara Nguyen, Jessica Necas, Clare et al.

Source: Pharmaceuticals (14248247). Nov2025, Vol. 18 Issue 11, p1764. 19p.

Epigenetic Regulation of Immune Responses in Endocrine-Related Cancers and Its Role in Immunotherapy.

Authors: Akyuz, Evren M. Gultekin, Meryem Ramage, Judith M. et al.

Source: Cancers. Oct2025, Vol. 17 Issue 20, p3342. 24p.

Claspin and Cancer: Where Are We Now?

Authors: Azenha, Diana Martins, Teresa C.

Source: International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 18, p8828. 31p.

Geniposide suppressed OX-LDL-induced osteoblast apoptosis by regulating the NRF2/NF-κB signaling pathway.

Authors: Xiao, Yaosheng Zhang, Shanshan Ye, Yongjun et al.

Source: Journal of Orthopaedic Surgery & Research. 11/18/2023, Vol. 18 Issue 1, p1-11. 11p.

AN ACOUSTOOPTIC INTERRACTION AT INFRALOW FREQUENCIES.

Authors: Khairetdinov, Marat Voskoboynikova, Gyulnara Poller, Boris et al.

Source: Proceedings of the International Multidisciplinary Scientific GeoConference SGEM. 2017, Vol. 17 Issue 2-3, p775-782. 8p.

Decoding the Epigenome of Breast Cancer.

Authors: Cortellesi, Elisa Savini, Isabella Veneziano, Matteo et al.

Source: International Journal of Molecular Sciences. Mar2025, Vol. 26 Issue 6, p2605. 33p.

Protective effects of sevoflurane conditioning against myocardial ischemia-reperfusion injury: a review of evidence from animal and clinical studies.

Authors: Lin, Jiefu Li, Xia Yang, Yuhui et al.

Source: Anesthesiology & Perioperative Science. Mar2025, Vol. 3 Issue 1, p1-19. 19p.

This result is not displayed to guests.
Login for full access.

Autophagy-Related Gene WD Repeat Domain 45B Promotes Tumor Proliferation and Migration of Hepatocellular Carcinoma through the Akt/mTOR Signaling Pathway.

Authors: Li, Jiahao Chen, Lansi Pang, Jingjing et al.

Source: Diagnostics (2075-4418). Mar2023, Vol. 13 Issue 5, p906. 18p.

The Tumour Microenvironment and Epigenetic Regulation in BRCA1 Pathogenic Variant-Associated Breast Cancers.

Authors: Tay, Jun Yu Ho, Josh Xingchong Cheo, Fan Foon et al.

Source: Cancers. Dec2024, Vol. 16 Issue 23, p3910. 19p.

LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition.

Authors: Nagasawa, Satoi Sedukhina, Anna S. Nakagawa, Yuko et al.

Source: PLoS ONE. Feb2015, Vol. 10 Issue 2, p1-12. 12p.

Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics.

Authors: Franz, Alexandra Coscia, Fabian Shen, Ciyue et al.

Source: Journal of Ovarian Research. 10/22/2021, Vol. 14 Issue 1, p1-14. 14p.

Current Advances in the Use of Tissue Engineering for Cancer Metastasis Therapeutics.

Authors: Katti, Preeya D. Jasuja, Haneesh

Source: Polymers (20734360). Mar2024, Vol. 16 Issue 5, p617. 23p.

Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks.

Authors: Stitzlein, Lea M. Adams, Jack T. Stitzlein, Erin N. et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 1/5/2024, Vol. 43 Issue 1, p1-20. 20p.

miR-876-5p suppresses breast cancer progression through targeting TFAP2A.

Authors: Xu, Jie Zheng, Jie Wang, Jian et al.

Source: Experimental & Therapeutic Medicine. Aug2019, Vol. 18 Issue 2, p1458-1464. 7p.

Drug Discovery Targeting Post-Translational Modifications in Response to DNA Damages Induced by Space Radiation.

Authors: Xie, Dafei Huang, Qi Zhou, Pingkun

Source: International Journal of Molecular Sciences. Apr2023, Vol. 24 Issue 8, p7656. 24p.